One CSL Message from the Chair 4 Message from the CEO 5 Performance CSL’s 2030 Strategy 8 CSL’s Sustainability Strategy 10 Value Creation 12 Material Risks 14 CSL’s Businesses and Outlook 16 Innovation Therapeutic Areas and Product Portfolio 20 Innovation 26 In this report 2024 13 August – Annual results and final dividend announcement 9 September – Shares trade ex‑dividend 10 September – Record date for final dividend 2 October – Final dividend paid 29 October – Annual General Meeting 31 December – Half Year ends 2025 11 February – Half Year results and interim dividend announcement 10 March – Shares trade ex‑dividend 11 March – Record date for interim dividend 9 April – Interim dividend paid 30 June – Full Year ends 19 August – Annual profit and final dividend announcement 9 September – Shares trade ex‑dividend 10 September – Record date for final dividend 3 October – Final dividend paid 28 October – Annual General Meeting 31 December – Half Year ends CSL Calender About this Report This Annual Report combines CSL’s financial and non-financial performance in one comprehensive report, linking our sustainability and strategic priorities to our business results. Unless otherwise stated, this report covers CSL’s controlled entities as disclosed within our consolidated entity disclosure statement included within our financial report. This 2024 Annual Report is a summary of CSL’s operations and activities for the 12-month period ended 30 June 2024 and financial position as at 30 June 2024. This report covers CSL’s global operations, including subsidiaries, unless otherwise noted. A reference to CSL, CSL Group, we, us and our and similar expressions refer collectively to CSL Limited and its related bodies corporate. Promising Futures Page 34 Annual General Meeting The 2024 Annual General Meeting (AGM) of CSL Limited (ABN 99 051 588 348) will be held on Tuesday, 29 October 2024 at 10 a.m. (Melbourne time) at RACV City Club, Level 17, 501 Bourke St, Melbourne 3000. Read more at investors.csl.com Healthier World Page 42 Governance Governance 56 Directors’ Report Remuneration Report 77 Financial Report Financial Report 106 Shareholder Information Shareholder Information 154 Distribution of Holdings 155 Glossary 159 Corporate Directory Back cover Operating and Financial Review 1
RkJQdWJsaXNoZXIy MjE2NDg3